Back to Index
Mojtaba Akhtari, MD
Associate Professor of Clinical Medicine
IRD 2020 Zonal Ave Off Campus Los Angeles


Dr. Mojtaba Akhtari is an Associate Professor of Clinical Medicine at Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California USC Norris Cancer Center/Keck Medical Center of USC. Before joining USC he served as an Assistant Professor of Medicine at the Division of Hematology and Oncology, University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. He is a Hematologist/Oncologist with medical and hematology/oncology training and experience in United Kingdom and United States of America. Dr. Akhtari is board certified in Internal Medicine, Hematology and Medical Oncology.

His experience is fairly wide ranging having worked in academic teaching medical centers and community hospitals with high clinical workloads and a heavy reliance on clinical skills. He is also a member of adult bone marrow transplantation team at USC. He has authored several book chapters and many articles in peer-reviewed journals. He received Humanism in Medicine Award at St. Francis Hospital of Evanston, Illinois. He is an active member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and American Society for Blood and Marrow Transplantation (ASBMT).


St. Francis Hospital of Evanston, IL: Humanism in Medicine Award

Keck School of Medicine, Department of Medicine: Faculty Teaching Award, 2014-2015

St. Francis Hospital of Evanston, IL : Humanism in Medicine Award, 2007


Sikaria S, Aldoss I, Akhtari M. Monoclonal Antibodies and Immune Therapies for Adult Precursor B-Acute Lymphoblastic Leukemia. Immunol Lett. 2016 Feb 23. View in: PubMed

Chow V, Weissman A, O'Connell CL, Mehrvar A, Akhtari M. Emerging treatment options for myelofibrosis: focus on pacritinib. Onco Targets Ther. 2016; 9:2655-65. View in: PubMed

Lee KJ, Chow V, Weissman A, Tulpule S, Aldoss I, Akhtari M. Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults. Ther Clin Risk Manag. 2016; 12:1301-10. View in: PubMed

Piatek CI, El-Hemaidi I, Feinstein DI, Liebman HA, Akhtari M. Management of immune-mediated cytopenias in pregnancy. Autoimmun Rev. 2015 Sep; 14(9):806-11. View in: PubMed

Granatowicz A, Piatek CI, Moschiano E, El-Hemaidi I, Armitage JD, Akhtari M. An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians. Korean J Fam Med. 2015 Sep; 36(5):197-202. View in: PubMed

Bhatt VR, Balasetti V, Abduall JJ, Giri S, Armitage JO, Loberiza FR, Bociek RG, Bierman PJ, Maness LJ, Vose JM, Fayad P, Akhtari M. Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2015 Jun 19. View in: PubMed

Piatek C, Akhtari M. Thrombocytopenia: optimizing approaches in cancer patients. Oncology (Williston Park). 2015 Apr; 29(4):297-8. View in: PubMed

Bhatt VR, Loberiza FR, Jing H, Bociek RG, Bierman PJ, Maness LJ, Vose JM, Armitage JO, Akhtari M. Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades. Clin Lymphoma Myeloma Leuk. 2015 Mar 5. View in: PubMed

Bowen JM, Perry AM, Quist E, Akhtari M. Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia. Case Rep Pathol. 2015; 2015:594970. View in: PubMed

Kedia S, Bhatt VR, Rajan SK, Tandra PK, El Behery RA, Akhtari M. Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection. Int J Prev Med. 2014 Dec; 5(Suppl 3):S179-S192. View in: PubMed

O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, Curtin P, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H. Chronic myelogenous leukemia, version 1. 2015. J Natl Compr Canc Netw. 2014 Nov; 12(11):1590-610. View in: PubMed

Mainali NR, Bhatt VR, Kedia S, Krishnamurthy J, Wake LM, Akhtari M. Reversible bone marrow aplasia induced by pegylated interferon-a-2a therapy in a patient with primary myelofibrosis. J Oncol Pharm Pract. 2014 Oct; 20(5):386-92. View in: PubMed

Bhatt VR, Akhtari M, Bociek RG, Sanmann JN, Yuan J, Dave BJ, Sanger WG, Kessinger A, Armitage JO. Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute myeloid leukemia. J Natl Compr Canc Netw. 2014 Jul; 12(7):963-8. View in: PubMed

Samiev D, Bhatt VR, Armitage JD, Maness LJ, Akhtari M. A primary care approach to myelodysplastic syndromes. Korean J Fam Med. 2014 May; 35(3):111-8. View in: PubMed

Owlia MB, Distler O, Foratyazdi M, Akhtari M. Visual Problem and Low Back Pain as Initial Manifestation of Multiple Myeloma Complicating Pre-existing Systemic Sclerosis. J Coll Physicians Surg Pak. 2014 Mar; 24 Suppl 1:S29-31. View in: PubMed

Aryal MR, Bhatt VR, Tandra P, Krishnamurthy J, Yuan J, Greiner TC, Akhtari M. Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages? Clin Lymphoma Myeloma Leuk. 2014 Feb; 14(1):e19-23. View in: PubMed

Owlia MB, Newman K, Akhtari M. Felty's Syndrome, Insights and Updates. Open Rheumatol J. 2014; 8:129-36. View in: PubMed

Akhtari M, Bhatt VR, Tandra PK, Krishnamurthy J, Horstman H, Dreessen A, Chen PX, Armitage JO. Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. Cancer Biol Ther. 2013 Dec; 14(12):1077-88. View in: PubMed

O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, Deangelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Pinilla-Ibarz J, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H. Chronic myelogenous leukemia, version 1. 2014. J Natl Compr Canc Netw. 2013 Nov 1; 11(11):1327-40. View in: PubMed

Newman K, Owlia MB, El-Hemaidi I, Akhtari M. Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new. Autoimmun Rev. 2013 May; 12(7):784-91. View in: PubMed

Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biol Blood Marrow Transplant. 2013 Mar; 19(3):460-7. View in: PubMed

Tang P, Perry AM, Akhtari M. A case of type B lactic acidosis in multiple myeloma. Clin Lymphoma Myeloma Leuk. 2013 Feb; 13(1):80-2. View in: PubMed

Tandra P, Krishnamurthy J, Bhatt VR, Newman K, Armitage JO, Akhtari M. Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths. Mediterr J Hematol Infect Dis. 2013; 5(1):e2013068. View in: PubMed

Neemann K, Eichele DD, Smith PW, Bociek R, Akhtari M, Freifeld A. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012 Dec; 14(6):E161-5. View in: PubMed

Prodduturi P, Perry AM, Aoun P, Weisenburger DD, Akhtari M. Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report. J Oncol Pharm Pract. 2012 Dec; 18(4):440-4. View in: PubMed

Algarni AA, Akhtari M, Fu K. Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature. Case Rep Hematol. 2012; 2012:207537. View in: PubMed

Newman K, Maness-Harris L, El-Hemaidi I, Akhtari M. Revisiting use of growth factors in myelodysplastic syndromes. Asian Pac J Cancer Prev. 2012; 13(4):1081-91. View in: PubMed

O'Brien S, Abboud CN, Akhtari M, Altman J, Berman E, DeAngelo DJ, Devine S, Fathi AT, Gotlib J, Jagasia M, Moore JO, Pinilla-Ibarz J, Radich JP, Reddy VV, Shah NP, Shami PJ, Smith BD, Snyder DS, Wetzler M, Yunus F. Chronic myelogenous leukemia. J Natl Compr Canc Netw. 2012 Jan; 10(1):64-110. View in: PubMed

Barber NA, Afzal W, Akhtari M. Hematologic toxicities of small molecule tyrosine kinase inhibitors. Target Oncol. 2011 Dec; 6(4):203-15. View in: PubMed

Baxley A, Akhtari M. Hematologic toxicities associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2011 Nov; 11(11):1663-7. View in: PubMed

Akhtari M. When to treat myelodysplastic syndromes. Oncology (Williston Park). 2011 May; 25(6):480-6. View in: PubMed

Newman KA, Akhtari M. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Autoimmun Rev. 2011 May; 10(7):432-7. View in: PubMed

Akhtari M, Giver CR, Ali Z, Flowers CR, Gleason CL, Hillyer CD, Kaufman J, Khoury HJ, Langston AA, Lechowicz MJ, Lonial S, Renfroe HM, Roback JD, Tighiouart M, Vaughn L, Waller EK. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion. 2010 Nov; 50(11):2424-31. View in: PubMed

Akhtari M, Waller EK. Howell-Jolly body-like inclusions in neutrophils. Blood. 2009 Oct 1; 114(14):2860. View in: PubMed

Akhtari M, Curtis B, Waller EK. Autoimmune neutropenia in adults. Autoimmun Rev. 2009 Sep; 9(1):62-6. View in: PubMed

Li JM, Giver CR, Lu Y, Hossain MS, Akhtari M, Waller EK. Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Immunotherapy. 2009 Jul; 1(4):599-621. View in: PubMed

Akhtari M, Waller EK, Jaye DL, Lawson DH, Ibrahim R, Papadopoulos NE, Arellano ML. Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). J Immunother. 2009 Apr; 32(3):322-4. View in: PubMed

Akhtari M, Waller EK. Howell-Jolly bodies in patients with chronic GVHD. Blood. 2009 Mar 5; 113(10):2125. View in: PubMed

Akhtari M, Langston AA, Waller EK, Gal AA. Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients. Bone Marrow Transplant. 2009 Jan; 43(2):155-8. View in: PubMed

Akhtari M, Mansuri J, Newman KA, Guise TM, Seth P. Biology of breast cancer bone metastasis. Cancer Biol Ther. 2008 Jan; 7(1):3-9. View in: PubMed

Lim ZY, Ingram W, Brand R, Akthari M, Milojkovic D, Ho AY, Devereux S, Pagliuca A, Duarte RF, Mufti GJ. Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant. 2007 Oct; 40(8):747-52. View in: PubMed

Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P. Targeting TGFbeta signaling for cancer therapy. Cancer Biol Ther. 2005 Mar; 4(3):261-6. View in: PubMed

Peyvandi F, Tuddenham EG, Akhtari AM, Lak M, Mannucci PM. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol. 1998 Mar; 100(4):773-6. View in: PubMed

Neerman-Arbez M, Antonarakis SE, Blouin JL, Zeinali S, Akhtari M, Afshar Y, Tuddenham EG. The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. Am J Hum Genet. 1997 Jul; 61(1):143-50. View in: PubMed

Powered bySC CTSI